Search

Your search keyword '"Lund O"' showing total 904 results
Start Over Author "Lund O"
904 results on '"Lund O"'

56. Sehnerv

Author

Lund, O. E., Aulhorn, Elfriede, Böke, Wilhelm, Friedburg, Dieter, Leydhecker, Wolfgang, Lund, Otto-Erich, Neubauer, Hellmut, Nover, Arno, Pau, Hans, Thiel, Hans-Jürgen, Witmer, Rudolf, and Wollensak, Josef

Published
1977
Full Text
View/download PDF

57. Netzhaut

Author

Lund, O. E., Aulhorn, Elfriede, Böke, Wilhelm, Friedburg, Dieter, Leydhecker, Wolfgang, Lund, Otto-Erich, Neubauer, Hellmut, Nover, Arno, Pau, Hans, Thiel, Hans-Jürgen, Witmer, Rudolf, and Wollensak, Josef

Published
1977
Full Text
View/download PDF

63. Machine learning competition in immunology – Prediction of HLA class I binding peptides

Author

Zhang, G. L., Ansari, H. R., Bradley, P., Cawley, G. C., Hertz, T., Hu, X., Jojic, N., Kim, Y., Kohlbacher, O., Lund, O., Lundegaard, C., Magaret, C. A., Nielsen, M., Papadopoulos, H., Raghava, G. P. S., Tal, V. -S, Xue, L. C., Yanover, C., Zhu, S., Rock, M. T., Crowe, J. E., Panayiotou, Christos G., Polycarpou, Marios M., Duch, W., Brusic, V., Panayiotou, Christos G. [0000-0002-6476-9025], and Polycarpou, Marios M. [0000-0001-6495-9171]

Subjects
Class (computer programming), Computer science, Histocompatibility Antigens Class I, Immunology, Peptide binding, Human leukocyte antigen, Competition (economics), Artificial Intelligence, Allergy and Immunology, Humans, Immunology and Allergy, Peptides, Algorithms, Protein Binding
Abstract

374 1-2 1 4

Published
2011
Full Text
View/download PDF

64. Norwegian patients and retail chicken meat share cephalosporin-resistant Escherichia coli and IncK/ bla CMY-2 resistance plasmids

Author

Berg, E.S., primary, Wester, A.L., additional, Ahrenfeldt, J., additional, Mo, S.S., additional, Slettemeås, J.S., additional, Steinbakk, M., additional, Samuelsen, Ø., additional, Grude, N., additional, Simonsen, G.S., additional, Løhr, I.H., additional, Jørgensen, S.B., additional, Tofteland, S., additional, Lund, O., additional, Dahle, U.R., additional, and Sunde, M., additional

Published
2017
Full Text
View/download PDF

65. Abstracts from Hydrocephalus 2016

Author

Adam, A., primary, Robison, J., additional, Lu, J., additional, Jose, R., additional, Badran, N., additional, Vivas-Buitrago, T., additional, Rigamonti, D., additional, Sattar, A., additional, Omoush, O., additional, Hammad, M., additional, Dawood, M., additional, Maghaslah, M., additional, Belcher, T., additional, Carson, K., additional, Hoffberger, J., additional, Jusué Torres, I., additional, Foley, S., additional, Yasar, S., additional, Thai, Q. A., additional, Wemmer, J., additional, Klinge, P., additional, Al-Mutawa, L., additional, Al-Ghamdi, H., additional, Carson, K. A., additional, Asgari, M., additional, de Zélicourt, D., additional, Kurtcuoglu, V., additional, Garnotel, S., additional, Salmon, S., additional, Balédent, O., additional, Lokossou, A., additional, Page, G., additional, Balardy, L., additional, Czosnyka, Z., additional, Payoux, P., additional, Schmidt, E. A., additional, Zitoun, M., additional, Sevestre, M. A., additional, Alperin, N., additional, Baudracco, I., additional, Craven, C., additional, Matloob, S., additional, Thompson, S., additional, Haylock Vize, P., additional, Thorne, L., additional, Watkins, L. D., additional, Toma, A. K., additional, Bechter, Karl, additional, Pong, A. C., additional, Jugé, L., additional, Bilston, L. E., additional, Cheng, S., additional, Bradley, W., additional, Hakim, F., additional, Ramón, J. F., additional, Cárdenas, M. F., additional, Davidson, J. S., additional, García, C., additional, González, D., additional, Bermúdez, S., additional, Useche, N., additional, Mejía, J. A., additional, Mayorga, P., additional, Cruz, F., additional, Martinez, C., additional, Matiz, M. C., additional, Vallejo, M., additional, Ghotme, K., additional, Soto, H. A., additional, Riveros, D., additional, Buitrago, A., additional, Mora, M., additional, Murcia, L., additional, Bermudez, S., additional, Cohen, D., additional, Dasgupta, D., additional, Curtis, C., additional, Domínguez, L., additional, Remolina, A. J., additional, Grijalba, M. A., additional, Whitehouse, K. J., additional, Edwards, R. J., additional, Eleftheriou, A., additional, Lundin, F., additional, Fountas, K. N., additional, Kapsalaki, E. Z., additional, Smisson, H. F., additional, Robinson, J. S., additional, Fritsch, M. J., additional, Arouk, W., additional, Garzon, M., additional, Kang, M., additional, Sandhu, K., additional, Baghawatti, D., additional, Aquilina, K., additional, James, G., additional, Thompson, D., additional, Gehlen, M., additional, Schmid Daners, M., additional, Eklund, A., additional, Malm, J., additional, Gomez, D., additional, Guerra, M., additional, Jara, M., additional, Flores, M., additional, Vío, K., additional, Moreno, I., additional, Rodríguez, S., additional, Ortega, E., additional, Rodríguez, E. M., additional, McAllister, J. P., additional, Guerra, M. M., additional, Morales, D. M., additional, Sival, D., additional, Jimenez, A., additional, Limbrick, D. D., additional, Ishikawa, M., additional, Yamada, S., additional, Yamamoto, K., additional, Junkkari, A., additional, Häyrinen, A., additional, Rauramaa, T., additional, Sintonen, H., additional, Nerg, O., additional, Koivisto, A. M., additional, Roine, R. P., additional, Viinamäki, H., additional, Soininen, H., additional, Luikku, A., additional, Jääskeläinen, J. E., additional, Leinonen, V., additional, Kehler, U., additional, Lilja-Lund, O., additional, Kockum, K., additional, Larsson, E. M., additional, Riklund, K., additional, Söderström, L., additional, Hellström, P., additional, Laurell, K., additional, Kojoukhova, M., additional, Sutela, A., additional, Vanninen, R., additional, Vanha, K. I., additional, Timonen, M., additional, Rummukainen, J., additional, Korhonen, V., additional, Helisalmi, S., additional, Solje, E., additional, Remes, A. M., additional, Huovinen, J., additional, Paananen, J., additional, Hiltunen, M., additional, Kurki, M., additional, Martin, B., additional, Loth, F., additional, Luciano, M., additional, Luikku, A. J., additional, Hall, A., additional, Herukka, S. K., additional, Mattila, J., additional, Lötjönen, J., additional, Alafuzoff, I., additional, Jurjević, I., additional, Miyajima, M., additional, Nakajima, M., additional, Murai, H., additional, Shin, T., additional, Kawaguchi, D., additional, Akiba, C., additional, Ogino, I., additional, Karagiozov, K., additional, Arai, H, additional, Reis, R. C., additional, Teixeira, M. J., additional, Valêncio, C. G., additional, da Vigua, D., additional, Almeida-Lopes, L., additional, Mancini, M. W., additional, Pinto, F. C. G., additional, Maykot, R. H., additional, Calia, G., additional, Tornai, J., additional, Silvestre, S. S. S., additional, Mendes, G., additional, Sousa, V., additional, Bezerra, B., additional, Dutra, P., additional, Modesto, P., additional, Oliveira, M. F., additional, Petitto, C. E., additional, Pulhorn, H., additional, Chandran, A., additional, McMahon, C., additional, Rao, A. S., additional, Jumaly, M., additional, Solomon, D., additional, Moghekar, A., additional, Relkin, N., additional, Hamilton, M., additional, Katzen, H., additional, Williams, M., additional, Bach, T., additional, Zuspan, S., additional, Holubkov, R., additional, Rigamonti, A., additional, Clemens, G., additional, Sharkey, P., additional, Sanyal, A., additional, Sankey, E., additional, Rigamonti, K., additional, Naqvi, S., additional, Hung, A., additional, Schmidt, E., additional, Ory-Magne, F., additional, Gantet, P., additional, Guenego, A., additional, Januel, A. C., additional, Tall, P., additional, Fabre, N., additional, Mahieu, L., additional, Cognard, C., additional, Gray, L., additional, Buttner-Ennever, J. A., additional, Takagi, K., additional, Onouchi, K, additional, Thompson, S. D., additional, Thorne, L. D., additional, Tully, H. M., additional, Wenger, T. L., additional, Kukull, W. A., additional, Doherty, D., additional, Dobyns, W. B., additional, Moran, D., additional, Vakili, S., additional, Patel, M. A., additional, Elder, B., additional, Goodwin, C. R., additional, Crawford, J. A., additional, Pletnikov, M. V., additional, Xu, J., additional, Blitz, A., additional, Herzka, D. A., additional, Guerrero-Cazares, H., additional, Quiñones-Hinojosa, A., additional, Mori, S., additional, Saavedra, P., additional, Treviño, H., additional, Maitani, K., additional, Ziai, W. C., additional, Eslami, V., additional, Nekoovaght-Tak, S., additional, Dlugash, R., additional, Yenokyan, G., additional, McBee, N., additional, and Hanley, D. F., additional

Published
2017
Full Text
View/download PDF

68. Stoichiometry of monoclonal antibody neutralization of T-cell line-adapted human immunodeficiency virus type 1.

Author

Schønning, Kristian, Lund, O, Lund, O S, Hansen, J E, Schønning, Kristian, Lund, O, Lund, O S, and Hansen, J E

Abstract

In order to study the stoichiometry of monoclonal antibody (MAb) neutralization of T-cell line-adapted human immunodeficiency virus type 1 (HIV-1) in antibody excess and under equilibrium conditions, we exploited the ability of HIV-1 to generate mixed oligomers when different env genes are coexpressed. By the coexpression of Env glycoproteins that either can or cannot bind a neutralizing MAb in an env transcomplementation assay, virions were generated in which the proportion of MAb binding sites could be regulated. As the proportion of MAb binding sites in Env chimeric virus increased, MAb neutralization gradually increased. Virus neutralization by virion aggregation was minimal, as MAb binding to HIV-1 Env did not interfere with an AMLV Env-mediated infection by HIV-1(AMLV/HIV-1) pseudotypes of CD4(-) HEK293 cells. MAb neutralization of chimeric virions could be described as a third-order function of the proportion of Env antigen refractory to MAb binding. This scenario is consistent with the Env oligomer constituting the minimal functional unit and neutralization occurring incrementally as each Env oligomer binds MAb. Alternatively, the data could be fit to a sigmoid function. Thus, these data could not exclude the existence of a threshold for neutralization. However, results from MAb neutralization of chimeric virus containing wild-type Env and Env defective in CD4 binding was readily explained by a model of incremental MAb neutralization. In summary, the data indicate that MAb neutralization of T-cell line-adapted HIV-1 is incremental rather than all or none and that each MAb binding an Env oligomer reduces the likelihood of infection.

Published
1999

78. Gene therapy of T helper cells in HIV infection: mathematical model of the criteria for clinical effect.

Author

Lund, O, Lund, O S, Gram, G, Nielsen, S D, Schønning, Kristian, Nielsen, Jens Ole, Hansen, J E, Mosekilde, E, Lund, O, Lund, O S, Gram, G, Nielsen, S D, Schønning, Kristian, Nielsen, Jens Ole, Hansen, J E, and Mosekilde, E

Abstract

This paper presents a mathematical analysis of the criteria for gene therapy of T helper cells to have a clinical effect on HIV infection. The analysis indicates that for such a therapy to be successful, it must protect the transduced cells against HIV-induced death. The transduced cells will not survive as a population if the gene therapy only blocks the spread of virus from transduced cells that become infected. The analysis also suggests that the degree of protection against disease-related cell death provided by the gene therapy is more important than the fraction cells that is initially transduced. If only a small fraction of the cells can be transduced, transduction of T helper cells and transduction of haematopoietic progenitor cells will result in the same steady-state level of transduced T helper cells. For gene therapy to be efficient against HIV infection, our analysis suggests that a 100% protection against viral escape must be obtained. The study also suggests that a gene therapy against HIV infection should be designed to give the transduced cells a partial but not necessarily total protection against HIV-induced cell death, and to avoid the production of viral mutants insensitive to the gene therapy.

Published
1997

84. Potyviral resistance derived from cultivars of Phaseolus vulgaris carrying bc-3 co-segregates with homozygotic presence of a mutated eIF4E allele

Author

Naderpour, M, Lund, O Søgaard, Larsen, R, and Johansen, E

Subjects
food and beverages
Abstract

In common bean, Phaseolus vulgaris, four recessive genes, bc-1, bc-2, bc-3 and bc-u control resistance to potyviruses Bean common mosaic virus (BCMV) and Bean common mosaic necrosis virus (BCMNV). To identify candidates for the bc-genes, we cloned and sequenced homologues of genes encoding cap-binding proteins, eIF4E, eIF(iso)4E and nCBP. In cultivars reported to carry bc-3 resistance, eIF4E was found to display non-silent mutations at codons 53, 65, 76 and 111 closely resembling a pattern of eIF4E mutations determining potyvirus resistance in other plant species. By application of a molecular marker in a segregating F2 population of P. vulgaris, BCMV resistance was found to co-segregate with homozygotic presence of the mutant eIF4E allele. , BCMV resistance was found to co-segregate with homozygotic presence of the mutant allele. Silent mutations were found in eIF(iso)4E, but without correspondence to P. vulgaris response to BCMV and BCMNV. No differences were found in cDNA of nCBP. In common bean, Phaseolus vulgaris, four recessive genes, bc-1, bc-2, bc-3 and bc-u control resistance to potyviruses Bean common mosaic virus (BCMV) and Bean common mosaic necrosis virus (BCMNV). To identify candidates for the bc-genes, we cloned and sequenced homologues of genes encoding cap-binding proteins, eIF4E, eIF(iso)4E and nCBP. In cultivars reported to carry bc-3 resistance, eIF4E was found to display non-silent mutations at codons 53, 65, 76 and 111 closely resembling a pattern of eIF4E mutations determining potyvirus resistance in other plant species. By application of a molecular marker in a segregating F2 population of P. vulgaris, BCMV resistance was found to co-segregate with homozygotic presence of the mutant eIF4E allele. , BCMV resistance was found to co-segregate with homozygotic presence of the mutant allele. Silent mutations were found in eIF(iso)4E, but without correspondence to P. vulgaris response to BCMV and BCMNV. No differences were found in cDNA of nCBP.

Published
2008

97. Zweite wissenschaftliche Sitzung

Author

Henkes, Herr, primary, Naumann, G., additional, Höpping, W., additional, Till, P., additional, Ossoinig, K., additional, Halama, J., additional, Babel, J., additional, Younessian, S., additional, Vogel, M. H., additional, Pesch, K. J., additional, Lund, O. E., additional, Toppel, Lieselotte, additional, Čurković, E., additional, Čupić, S., additional, and Shimizu, K., additional

Published
1969
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results